This week in Washington: House to hold hearings on PFAS contamination and exposure, the maternal mortality crisis and single-payer issues....more
5/14/2019
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Budget Office ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
GAO ,
Inpatient Prospective Payment System (IPPS) ,
Medicare ,
Medicare Access and CHIP Reauthorization (MACRA) ,
Pharmacy Benefit Manager (PBM) ,
Popular ,
Prescription Drugs ,
Trump Administration
This week in Washington: Hearings continue on the price of prescription drugs, Senate Committee on Finance to hold a hearing on Medicare physician payment reform, while the Senate HELP Committee will hold its second hearing...more
5/7/2019
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Inpatient Prospective Payment System (IPPS) ,
Medicare ,
Medicare for All ,
Medicare Part B ,
Medicare Part D ,
Pharmaceutical Industry ,
Popular ,
Prescription Drugs ,
Trump Administration
Upcoming Hearings/Markups -
Tuesday, April 30, 2019 -
House Committee on Rules: “Hearing on the Medicare for All Act of 2019,” H.R. 1384 -
The House Committee on Rules will hold a hearing on the Medicare for All Act...more
Congress -
Hearings/Markups -
House Judiciary Committee: "TBA Markup on CREATES Act, Pay-for-Delay Legislation" -
The House Judiciary Committee is planning a markup on the CREATES Act and pay-for-delay legislation....more
Congress -
Hearings/Markups -
Senate Finance Committee: "Drug Pricing in America: A Prescription for Change, Part III" -
Tuesday, April 9, 2019: The Senate Finance Committee continued its drug pricing series by...more
4/16/2019
/ Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Medicare ,
Medicare for All ,
OMB ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Trump Administration
Coming Week’s Highlights: Congress will continue to examine drug pricing; on Tuesday, the Senate Finance Committee will hold the third in a series of hearings, this one focused on pharmacy benefit managers (PBMs). The House...more
4/9/2019
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
OMB ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Popular ,
Prescription Drugs
Upcoming Hearings -
Tuesday, April 2, 2019 -
House Committee on Energy and Commerce: “Priced Out of a Lifesaving Drug: The Human Impact of Rising Insulin Costs” -
The Subcommittee on Oversight and Investigations of the...more
4/2/2019
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Department of Justice (DOJ) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
GAO ,
OIG ,
Opioid ,
Pharmacy Benefit Manager (PBM) ,
Popular ,
Prescription Drugs
Upcoming Hearings -
Tuesday, March 26, 2019 -
House Committee on the Budget: “Department of Health and Human Services FY2020 Budget” -
The House Committee on the Budget will hold a hearing examining the proposed...more
Upcoming Hearings -
Tuesday, March 26, 2019 -
Senate Committee on Health, Education, Labor and Pensions (HELP): “Implementing the 21st Century Cures Act: Making Electronic Health Information Available to Patients and...more
Coming Week’s Highlights: CMS seeks recommendations that allow Americans to purchase health insurance across state lines, House to hold hearings on the 2020 HHS budget and lowering the cost of prescription drugs....more
Upcoming Hearings -
Tuesday, March 5, 2019 -
Senate Committee on Health, Education, Labor and Pensions (HELP): “Vaccines Save Lives: What is Driving Preventable Disease Outbreaks?” -
The Senate Committee on Health,...more
3/5/2019
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Comment Period ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Health Insurance Portability and Accountability Act (HIPAA) ,
Medicare ,
OMB ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs
Upcoming Hearings -
Tuesday, Feb. 26, 2019 -
Senate Finance Committee: “Drug Pricing in America: A Prescription for Change, Part II” -
The second hearing in a series on drug pricing in the Senate Finance Committee...more
2/26/2019
/ Centers for Medicare & Medicaid Services (CMS) ,
Children's Health Insurance Program (CHIP) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
HELP ,
Medicare Advantage ,
Medicare Part D ,
OMB ,
Pharmaceutical Industry ,
Prescription Drugs ,
Proposed Rules ,
Vaccinations
Upcoming Hearings -
Tuesday, Feb. 26, 2019 -
Senate Finance Committee: “TBA Hearing on Drug Pricing” -
The second hearing in a series on drug pricing in the Senate Finance Committee will include the testimonies of...more
2/19/2019
/ Centers for Medicare & Medicaid Services (CMS) ,
Comment Period ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Health Care Providers ,
Medicare ,
Medicare Part D ,
OMB ,
Opioid ,
Pharmaceutical Industry ,
Prescription Drugs ,
Trump Administration
Coming Week’s Highlights: This week’s focus by many will be whether the government shuts down once more. Legislation must be passed and signed by the President by February 15, in order to keep the departments not yet funded...more
2/12/2019
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Food and Drug Administration (FDA) ,
Health Care Providers ,
Medicaid ,
Medicare ,
Pharmaceutical Industry ,
Prescription Drugs ,
Trump Administration
Coming Week’s Highlights: State of the Union scheduled for Feb. 5; House committees continue discussion on pre-existing conditions....more
2/5/2019
/ Affordable Care Act ,
Centers for Medicare & Medicaid Services (CMS) ,
Congressional Budget Office ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
GAO ,
Medicare ,
Medicare Advantage ,
Medicare Part D ,
Pharmaceutical Industry ,
Pharmacy Benefit Manager (PBM) ,
Prescription Drugs ,
Section 340B
Government Shutdown: An agreement was reached and those parts of the federal government that were shut down will reopen today. The agreement is good until Feb. 15. As a reminder, the only portion of the U.S. Department of...more
House -
New Leadership Updates -
On Jan. 9, eight Democratic members were added to the House Energy and Commerce Committee:
Reps. Nanette Diaz Barragan (CA), Robin Kelly (IL), Marc Veasey (TX), Tom O’Halleran (AZ),...more
This Week: The Affordable Care Act was found unconstitutional, but nothing will change as it winds through the courts. As the 115th Congress comes to a close, last-minute bills are introduced, some healthcare legislation...more
The omnibus appropriations legislation that Congress passed last week contained a variety of health-related provisions. These provisions include rescinding funding for the Independent Payment Advisory Board (IPAB),...more
On Monday, March 23, the U.S. Department of Health and Human Services (HHS) and the Centers for Medicare and Medicaid Services (CMS) issued a notice of proposed rulemaking for Stage 3 Meaningful Use of Electronic Health...more